How Bari Kowal and Regeneron Are Redesigning Clinical Trials for Speed, Access, and Impact
About Bari Kowal:
Bari Kowal is a senior biopharmaceutical executive with over 30 years of experience leading global operations, clinical development, and strategic portfolio management. As Senior Vice President at Regeneron, she oversees development operations, enterprise-wide portfolio strategy, risk management, and major technology initiatives, helping guide the company’s continued growth and innovation. Her career spans leadership roles at Pfizer, ICON Clinical Research, Valera Pharmaceuticals, PDL BioPharma, GenVec, and Covance, where she built high-performing teams and drove operational…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.